Home Newsfeeds Goldman Sachs Upgrades Immunocore Hldgs to Buy

Goldman Sachs Upgrades Immunocore Hldgs to Buy

Goldman Sachs analyst Rajan Sharma upgrades Immunocore Hldgs (NASDAQ:IMCR) from Neutral to Buy.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Goldman Sachs analyst Rajan Sharma upgrades Immunocore Hldgs (NASDAQ:IMCR) from Neutral to Buy.

News

‘Evidence Shows AI-Driven Companies Are Buying Up Gaming GPUs’ – Tom’s Hardware

By Happy Mohamed

August 1, 1:01 PM

https://www.tomshardware.com/news/evidence-shows-ai-driven-companies-are-buying-up-gaming-gpus Demand for GPUs is unquestionably ramping up again as prices eclipse $70,000 per GPU in some China

Defying Wall Street Skepticism, Gary Black Envisions Tesla’s Cybertruck Driving 600,000 Deliveries By 2027

By Anan Ashraf

December 5, 2:18 AM

Tesla Inc (NASDAQ:TSLA) investor and Future Fund Managing Partner, Gary Black, sees the newly delivered Cybertrucks taking the EV giant…

TSLA

Matinas BioPharma Announces Positive Opinion By The European Medicines Agency On Orphan Drug Designation For MAT2203 For The Treatment Of Cryptococcosis

By Benzinga Newsdesk

July 25, 6:31 AM

Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform

MTNB